NHS Logo
  • Home
  • About Us
    • NIHR Imperial BRC Team
    • Equality, Diversity and Inclusion (EDI) Strategy
    • NIHR Infrastructures
    • Acknowledgement
    • Research Guidance & Useful Links
    • NIHR Imperial BRC Branding Guidance
  • Research
    • Biomedical Engineering
    • Brain Sciences
    • Cardiovascular
    • Digestive Diseases
    • Digital Health
    • Immunology
    • Infection & Antimicrobial Resistance
    • Metabolic & Endocrinology
    • Molecular Phenotyping
    • Multiple Long-term Conditions (MLTC)
    • Pregnancy & Prematurity
    • Respiratory
    • Social, Genetic & Environmental Determinants of Health (SGE)
    • Surgery & Cancer
  • Facilities/Services
    • Clinical Imaging Facility
    • Clinical Phenotyping Centre
    • Flow Cytometry
    • Genomics Facility
    • Imperial College Healthcare Tissue Bank
    • iCARE
    • Imperial Clinical Trials Unit
    • Imperial Health Knowledge Bank (IHKB)
    • Organoid Facility
    • Patient Experience Research Centre (PERC)
    • The Leonard and Dora Colebrook Laboratory
  • Patient/Public
    • Research We Are Supporting
    • How You Can Get Involved
    • Information for Researchers
    • Public Involvement, Engagement and Participation in Research Summary Strategy
  • Industry/Partners
    • Collaborations
    • Contract
    • Commercialisation
  • Training
    • Non-Medical Opportunities
    • Chain Florey Clinician Scientist Programme
    • Clinical Academic Training Office
    • Other Training Schemes
  • News & Events
    • Impact Stories
    • Upcoming Events
    • Newsletter
  • Contact Us

Treatment Stories

TherapeuticTreatment Long COVID leads to inflammatory markers in the blood

TherapeuticTreatment Long COVID leads to inflammatory markers in the blood

Published on 9th April 2024
Treatment UK cancer patients receive experimental mRNA therapy for the first time

Treatment UK cancer patients receive experimental mRNA therapy for the first time

Published on 5th February 2024
DiagnosticPreventionTherapeuticTreatment Meet the Team Leading the Charge Against Cervical Cancer

DiagnosticPreventionTherapeuticTreatment Meet the Team Leading the Charge Against Cervical Cancer

Published on 29th January 2024
DiagnosticPartnershipTherapeuticTreatment Antimicrobial Resistance: Securing the Future

DiagnosticPartnershipTherapeuticTreatment Antimicrobial Resistance: Securing the Future

Published on 5th December 2023
Treatment New world-first gene-editing treatment for blood disorders gets the green light

Treatment New world-first gene-editing treatment for blood disorders gets the green light

Published on 16th November 2023
Information for Patients and the Public
  • Research We Are Supporting
  • How You Can Get Involved
  • Public Involvement, Engagement and Participation in Research Summary Strategy
Latest News
  • Appointment The UK DRI Centre for Care Research & Technology announced new leader
  • Prevention Research participation opportunity- COVCHIM02 – COVID-19 Challenge Study
  • Prevention Enhancing Dementia Care Through Innovative Home Monitoring Initiative
NIHR Imperial Biomedical Research Centre

The National Institute for Health and Care Research (NIHR) Imperial Biomedical Research Centre (BRC) is part of the NIHR and hosted by Imperial College Healthcare NHS Trust in partnership with Imperial College London


Accessibility
Privacy
Terms & Conditions

The information contained in this website is for general use only. We endeavour to keep the information on the site up to date and correct, but we make no representations or warranties of any kind, express or implied, about the completeness, accuracy, reliability, suitability or availability with respect to the website or the information, products, services, or related graphics contained on the website for any purpose.

© 2025 - NIHR Imperial Biomedical Research Centre